Shareholding disclosure

The Swiss Helvetia Fund Inc

Declared position

2.92%

Threshold

Crossed upwards

Timeline

Published

09.11.2012

Transaction

17.10.2012

Voting rights breakdown

Voting rights acquired2.92%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TACB800019

Beneficial owner

The Swiss Helvetia Fund Inc

Declared address

THE SWISS HELVETIA FUND, INC., NEW YORK 10020

Change in registered capital.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

The Swiss Helvetia Fund Inc

Addex Therapeutics Ltd09.11.2012TACB800019

Disclosure summary

The Swiss Helvetia Fund Inc disclosed a holding in Addex Therapeutics Ltd on the acquisition side, published by SIX Exchange Regulation on 09.11.2012, at 2.92% of voting rights. Notice category: Single shareholder.

Disclosed position

2.92%

Voting rights acquired

Voting rights acquired2.92%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

The Swiss Helvetia Fund Inc disclosed a holding in Addex Therapeutics Ltd, published on 09.11.2012.

Publication date09.11.2012

Transaction date17.10.2012

Issuing companyAddex Therapeutics Ltd

Beneficial ownerThe Swiss Helvetia Fund Inc

Declared addressTHE SWISS HELVETIA FUND, INC., NEW YORK 10020

CategorySingle shareholder

Voting rights acquired2.92%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTACB800019

Conditions

Change in registered capital.

Source: SIX Exchange Regulation · Publication date: 09.11.2012

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open